Company profile for XNK Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy. XNK Therapeutics focuses on cancer treatment by developing novel autologous NK cell-based therapies. This effort is strongly supported by the founding shareholders holding expertise in the field.XNK Therapeutics has actively been participating in public-private partnerships to develop its technology platform. To date, th...
XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy. XNK Therapeutics focuses on cancer treatment by developing novel autologous NK cell-based therapies. This effort is strongly supported by the founding shareholders holding expertise in the field.XNK Therapeutics has actively been participating in public-private partnerships to develop its technology platform. To date, the main collaborating academic partners have been Karolinska Institutet and the Royal Institute of Technology, both in Stockholm, Sweden.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Sweden
Address
Address
Hälsovägen 7, Novum 141 57 Huddinge
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/xnk-therapeutics-to-present-at-redeye-regenerative-medicinecell-therapy-event-302057229.html

PR NEWSWIRE
08 Feb 2024

https://www.prnewswire.com/news-releases/xnk-therapeutics-receives-ema-scientific-recommendation-for-evencaleucel-as-an-advanced-therapy-medicinal-product-302034513.html

PR NEWSWIRE
15 Jan 2024

https://www.prnewswire.com/news-releases/xnk-therapeutics-to-present-at-dnb-nordic-healthcare-conference-in-oslo-302004358.html

PR NEWSWIRE
04 Dec 2023

https://www.prnewswire.com/news-releases/xnk-therapeutics-to-present-at-investival-showcase-meeting-301984424.html

PR NEWSWIRE
10 Nov 2023

https://www.prnewswire.com/news-releases/xnk-therapeutics-announces-poster-presentations-at-the-38th-annual-meeting-of-the-society-for-immunotherapy-of-cancer-sitc-301978264.html

PR NEWSWIRE
06 Nov 2023

https://www.prnewswire.com/news-releases/xnk-therapeutics-presented-two-posters-at-the-nk2023-conference-in-oslo-301939917.html

PR NEWSWIRE
27 Sep 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty